Showing 3781-3790 of 5333 results for "".
- Minimizing Risks of Cosmetic Procedures in Patients with Darker Skin Typeshttps://practicaldermatology.com/news/minimizing-risks-of-cosmetic-procedures-in-patients-with-darker-skin-types/2460784/With cosmetic procedures in high demand during the pandemic, Cedars-Sinai dermatologist Jasmine Obioha, MD, has seen an unfortunate side effect: botched treatments for patients of color. When performed improperly, procedures such as chemical peels and laser hair removal can inflame and
- Skin Cancer Foundation Champions for Change Gala Goes Virtualhttps://practicaldermatology.com/news/skin-cancer-foundation-champions-for-change-gala-goes-virtual/2460783/The Champions for Change Gala, the Skin Cancer Foundation’s signature fundraising event, be held virtually, Tuesday, May 11. Proceeds from the annual event support the organization’s educational campaigns, community programs, and research initiatives. The event will be
- Cynosure Expands Its Potenza RF Microneedling System with New Fusion Tip for Enhanced Topical Penetrationhttps://practicaldermatology.com/news/cynosure-expands-its-potenza-rf-microneedling-system-with-new-fusion-tip-for-enhanced-topical-penetration/2460781/The Fusion Tip is the latest addition to Cynosure's Potenza system, its four-mode RF microneedling device, which uses ultrafine needles and RF energy to penetrate the top layer of the skin, triggering the body's natural healing process to regenerate new collagen and elastin.
- New York City's Mount Sinai Launches Melanoma and Skin Cancer Centerhttps://practicaldermatology.com/news/new-york-citys-mount-sinai-launches-melanoma-and-skin-cancer-center/2460777/Mount Sinai received a second $10 million gift from the Waldman Family to open the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center at Mount Sinai. Housed within the Kimberly and Eric J. Waldman Department of Dermatology at the May
- Accure Acne Seeks to Raise Up To $20 Million Through Private Placement Offeringhttps://practicaldermatology.com/news/accure-acne-seeks-to-raise-up-to-20-million-through-private-placement-offering/2460776/Accure Acne, Inc. has launched a private placement offering on the M-Vest platform to raise up to $20 Million. Building on the research of R. Rox Anderson, MD, Accure Co-Founder and Chief Scientific & Medical Officer, Accure has developed the Accure Laser System, an&n
- San Francisco Dermatologist Bill Kwan Featured in Third Albumhttps://practicaldermatology.com/news/san-francisco-dermatologist-bill-kwan-featured-in-third-album/2460773/As a dermatologist, Bill Kwan, MD plies his craft as the provider of both medical and aesthetic care to patients in San Francisco. As a vocalist, he plies his craft sharing the art of music. Dr. Kwan has released "No Ordinary Love: The Music of Sade." The third album that features Dr. K
- New Studies Support Taltz’s Role in Treating Psoriasishttps://practicaldermatology.com/news/new-studies-support-taltzs-role-in-treating-psoriasis/2460771/Lilly's Taltz delivers more cumulative days with completely clear skin for adults with psoriasis, compared to seven other biologics. What’s more, Taltz also helped patients stay on treatment longer and have more days without additional therapy in three real-world analyses of U
- Dermavant: Posters Unveil Additional Data for Once-Daily Topical Tapinarofhttps://practicaldermatology.com/news/dermavant-posters-unveil-additional-data-for-once-daily-topical-tapinarof/2460770/Dermavant Sciences will present data in poster form from its two pivotal phase 3 trials for tapinarof for the treatment of psoriasis in adults, PSOARING 1 and PSOARING 2, at AAD VMX 2021. Tapinarof is a novel, once-daily therapeutic aryl hydrocarbon recepto
- Etrasimod Performs Well in Phase Phase 2b Trial of Adult Atopic Dermatitishttps://practicaldermatology.com/news/etrasimod-performs-well-in-phase-phase-2b-trial-of-adult-atopic-dermatitis/2460761/Arena Pharmaceuticals, Inc.’s Etrasimod demonstrated statistical significance in both clinician and patient reported outcomes in atopic dermatitis, according to research presented at the American Academy of Dermatology VMX Experience. Etrasimod is an investigational, highly select
- DermTech Launches DermTech PLAplushttps://practicaldermatology.com/news/dermtech-launches-dermtech-plaplus/2460759/DermTech has launched DermTech PLAplus (TM), its next generation test for the enhanced early detection of melanoma, intended to provide objective and actionable information to guide clinical management decisions for skin lesions suspicious of melanoma.